|

COVID-19 Vaccines at a 3-month interval Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • McGill University Health Centre/Research Institute of the McGill University Health Centre1

Indications

  • People Living With HIV1
  • Immunocompromised Host1
  • Solid Organ Transplant Recipients1
  • Rheumatoid Arthritis (RA1
  • Influenza1

Other1 trial

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.